<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR36006</article-id>
      <title-group>
        <article-title>Proniosomes: A Recent Advancement In Nanotechnology As A Absorption Modulator for Transdermal Drug Delivery System</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Chandra</surname>
            <given-names>Dinesh</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kumar</surname>
            <given-names>Ashish</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>singh</surname>
            <given-names>Rakesh</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Raj</surname>
            <given-names>Tirth</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Verma</surname>
            <given-names>Shrikant</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sharma</surname>
            <given-names>Niraj</given-names>
          </name>
        </contrib>
      </contrib-group>
      <pub-date pub-type="epub" iso-8601-date="2013-12-01">
        <month>12</month>
        <day>01</day>
        <year>2013</year>
      </pub-date>
      <volume>3</volume>
      <issue>6</issue>
      <abstract>
        <p>The proniosomal approach helps to solve the problem regarding stability and provides higher entrapment efficiency over conventional system. Proniosomal gel is a liquid crystalline- compact niosomal hybrid which is prepared by dissolving surfactant in small amount of suitable solvent and least amount of aqueous phase. This compact gel can be converted to niosomes hydration. Proniosomes can entrap hydrophilic as well as lipophillic drugs. Proniosomal gel offers a versatile vesicle drug delivery concept with potential for drug delivery via transdermal rout. Over the last few years an inclusive research has been done over pro-vesicular approach for transdermal drug delivery. Skin has a very tough diffusion barrier inhibiting penetration of drug moiety which is rate limiting barrier for penetration of drugs. There are several approaches that deal with penetration enhancement across the skin. Vesicular and provesicular systems are promising amongst them. Vesicular systems including (niosomes, ethosomes, transfersomes and liposomes) are promising systems to cross this permeation barrier.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Proniosomes</kwd>
        <kwd>Niosomes</kwd>
        <kwd>skin penetration</kwd>
        <kwd>stability</kwd>
        <kwd>transdermal</kwd>
        <kwd>coacervation.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
